PIM
Platinum Investment Management Portfolio holdings
AUM
$1.5B
1-Year Return
16.62%
This Quarter Return
+25.8%
1 Year Return
+16.62%
3 Year Return
+100.57%
5 Year Return
+187.54%
10 Year Return
+422.09%
AUM
$4.38B
AUM Growth
+$420M
(+11%)
Cap. Flow
-$411M
Cap. Flow
% of AUM
-9.39%
Top 10 Holdings %
Top 10 Hldgs %
55.94%
Holding
134
New
17
Increased
28
Reduced
47
Closed
10
Top Buys
| 1 |
GE Aerospace
GE
|
$93.2M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$68.4M |
| 3 |
Carrier Global
CARR
|
$61.3M |
| 4 |
Trip.com Group
TCOM
|
$54.7M |
| 5 |
Vail Resorts
MTN
|
$39.3M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$110M |
| 2 |
Skyworks Solutions
SWKS
|
$100M |
| 3 |
Moderna
MRNA
|
$96.6M |
| 4 |
WUBA
58.COM INC
WUBA
|
$94.8M |
| 5 |
ZTO Express
ZTO
|
$84M |
Sector Composition
| 1 | Consumer Discretionary | 28.01% |
| 2 | Technology | 21.97% |
| 3 | Industrials | 16.54% |
| 4 | Communication Services | 16.31% |
| 5 | Healthcare | 7.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Adaptive Biotechnologies
ADPT
$1.98B
| $2.37M | 0.05% |
48,890
+4,108
| +9% | +$199K |
|
77
Cardinal Health
CAH
$35.7B
| $2.33M | 0.05% |
+44,670
| New | +$2.33M |
|
78
Revvity
RVTY
$9.95B
| $2.29M | 0.05% |
23,334
-3,484
| -13% | -$342K |
|
79
Ovid Therapeutics
OVID
$91.7M
| $2.22M | 0.05% |
301,589
-81,346
| -21% | -$600K |
|
80
BioCryst Pharmaceuticals
BCRX
$1.74B
| $2.2M | 0.05% |
462,402
-308,984
| -40% | -$1.47M |
|
81
Sangamo Therapeutics
SGMO
$160M
| $2.16M | 0.05% |
240,512
-5,328
| -2% | -$47.7K |
|
82
Arcus Biosciences
RCUS
$1.23B
| $2.15M | 0.05% |
87,058
-16,682
| -16% | -$413K |
|
|
ORTX
83
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $2.14M | 0.05% |
35,702
+21,819
| +157% | +$1.31M |
|
|
CBMG
84
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
| $2.04M | 0.05% |
135,921
-415,598
| -75% | -$6.22M |
|
|
FPRX
85
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $2M | 0.05% |
327,414
+76,198
| +30% | +$465K |
|
|
86
Moderna
MRNA
$9.45B
| $1.99M | 0.05% |
31,060
-1,504,855
| -98% | -$96.6M |
|
87
Apple
AAPL
$3.56T
| $1.96M | 0.04% |
21,448
| – | – |
|
88
Zymeworks
ZYME
$1.07B
| $1.89M | 0.04% |
52,327
| – | – |
|
|
XLRN
89
DELISTED
Acceleron Pharma Inc.
XLRN
| $1.89M | 0.04% |
19,800
-3,087
| -13% | -$294K |
|
90
Dianthus Therapeutics
DNTH
$794M
| $1.81M | 0.04% |
15,091
-1,218
| -7% | -$146K |
|
91
Intellia Therapeutics
NTLA
$1.25B
| $1.76M | 0.04% |
83,737
| – | – |
|
92
Denali Therapeutics
DNLI
$2.16B
| $1.71M | 0.04% |
70,793
| – | – |
|
93
Cisco
CSCO
$269B
| $1.67M | 0.04% |
35,700
| – | – |
|
94
Oracle
ORCL
$626B
| $1.63M | 0.04% |
29,418
| – | – |
|
|
PVLA
95
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $1.58M | 0.04% |
6,360
+2,562
| +67% | +$635K |
|
96
Fulcrum Therapeutics
FULC
$372M
| $1.53M | 0.03% |
83,550
-11,983
| -13% | -$219K |
|
97
Bio-Rad Laboratories Class A
BIO
$7.83B
| $1.39M | 0.03% |
3,068
-1,107
| -27% | -$500K |
|
98
Alector
ALEC
$285M
| $1.38M | 0.03% |
56,240
| – | – |
|
|
CNTG
99
DELISTED
Centogene N.V. Common Shares
CNTG
| $1.35M | 0.03% |
+59,080
| New | +$1.35M |
|
100
Prothena Corp
PRTA
$442M
| $1.34M | 0.03% |
128,223
| – | – |
|